Refractory Angina Treatment Market is driven by Innovative TherapeuticsNew Section
Refractory angina, characterized by chronic chest pain unresponsive to standard medical and revascularization therapies, affects a significant subset of ischemic heart disease patients. The market offers a spectrum of advanced interventions—including novel pharmacological agents (such as ivabradine and ranolazine), gene therapy vectors, cell-based regenerative treatments, enhanced...
0 Yorumlar 0 hisse senetleri 120 Views 0 önizleme